METHODS: Using flow cytometry we evaluated 18 human lung cancer cell lines for the expression of different surface markers on lung cancers suggested to be possible prognostic parameters, including epidermal growth factor receptor ( EGFR), intercellular adhesion molecule 1 ( ICAM - 1), Fas and CD40.	"human	46	51	Organism"	"lung cancer cell lines	52	74	Cell"	"lung cancers	126	138	Cancer"	"epidermal growth factor receptor	197	229	Gene_or_gene_product"	"EGFR	232	236	Gene_or_gene_product"	"intercellular adhesion molecule 1	239	272	Gene_or_gene_product"	"ICAM - 1	275	283	Gene_or_gene_product"	"Fas	286	289	Gene_or_gene_product"	"CD40	294	298	Gene_or_gene_product"	"[{""token"": ""human"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Organism""}, {""token"": ""lung cancer cell lines"", ""start_span"": 52, ""end_span"": 74, ""type"": ""Cell""}, {""token"": ""lung cancers"", ""start_span"": 126, ""end_span"": 138, ""type"": ""Cancer""}, {""token"": ""epidermal growth factor receptor"", ""start_span"": 197, ""end_span"": 229, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGFR"", ""start_span"": 232, ""end_span"": 236, ""type"": ""Gene_or_gene_product""}, {""token"": ""intercellular adhesion molecule 1"", ""start_span"": 239, ""end_span"": 272, ""type"": ""Gene_or_gene_product""}, {""token"": ""ICAM - 1"", ""start_span"": 275, ""end_span"": 283, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas"", ""start_span"": 286, ""end_span"": 289, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD40"", ""start_span"": 294, ""end_span"": 298, ""type"": ""Gene_or_gene_product""}]"
Patients with liver and / or bone metastases had significantly higher median concentrations of S - 100beta, IL - 6 and IL - 10 than those with only skin, nodal and / or lung involvement.	"Patients	0	8	Organism"	"liver	14	19	Organ"	"bone	29	33	Organ"	"S - 100beta	95	106	Gene_or_gene_product"	"IL - 6	108	114	Gene_or_gene_product"	"IL - 10	119	126	Gene_or_gene_product"	"skin	148	152	Organ"	"nodal	154	159	Multi"	"lung	169	173	Organ"	"[{""token"": ""Patients"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Organism""}, {""token"": ""liver"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Organ""}, {""token"": ""bone"", ""start_span"": 29, ""end_span"": 33, ""type"": ""Organ""}, {""token"": ""S - 100beta"", ""start_span"": 95, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 6"", ""start_span"": 108, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 10"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}, {""token"": ""skin"", ""start_span"": 148, ""end_span"": 152, ""type"": ""Organ""}, {""token"": ""nodal"", ""start_span"": 154, ""end_span"": 159, ""type"": ""Multi""}, {""token"": ""lung"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Organ""}]"
The therapeutic options available in this regard include measures that: down - regulate serum free IGF - I; suppress the synthesis of mevalonic acid and / or certain derivatives thereof; modulate arachidonate metabolism by inhibiting 5 - lipoxygenase, 12 - lipoxygenase, or COX - 2; antagonize the activation of AP - 1 transcription factors; promote the activation of PPAR - gamma transcription factors; and that suppress angiogenesis by additional mechanisms.	"serum	88	93	Organism_substance"	"IGF - I	99	106	Gene_or_gene_product"	"mevalonic acid	134	148	Chemical"	"arachidonate	196	208	Chemical"	"5 - lipoxygenase	234	250	Gene_or_gene_product"	"12 - lipoxygenase	252	269	Gene_or_gene_product"	"COX - 2	274	281	Gene_or_gene_product"	"AP - 1	312	318	Gene_or_gene_product"	"PPAR - gamma	368	380	Gene_or_gene_product"	"[{""token"": ""serum"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Organism_substance""}, {""token"": ""IGF - I"", ""start_span"": 99, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""mevalonic acid"", ""start_span"": 134, ""end_span"": 148, ""type"": ""Chemical""}, {""token"": ""arachidonate"", ""start_span"": 196, ""end_span"": 208, ""type"": ""Chemical""}, {""token"": ""5 - lipoxygenase"", ""start_span"": 234, ""end_span"": 250, ""type"": ""Gene_or_gene_product""}, {""token"": ""12 - lipoxygenase"", ""start_span"": 252, ""end_span"": 269, ""type"": ""Gene_or_gene_product""}, {""token"": ""COX - 2"", ""start_span"": 274, ""end_span"": 281, ""type"": ""Gene_or_gene_product""}, {""token"": ""AP - 1"", ""start_span"": 312, ""end_span"": 318, ""type"": ""Gene_or_gene_product""}, {""token"": ""PPAR - gamma"", ""start_span"": 368, ""end_span"": 380, ""type"": ""Gene_or_gene_product""}]"
Treatment of REF or REF expressing full - length T antigen, an N - terminal segment, or T251 - 708 resulted in increased expression of the p53 - responsive MDM2 gene; apoptosis occurred through a p53 - dependent pathway, as p53 - null cells expressing these T antigens were resistant to 5 - FU - induced apoptosis.	"REF	13	16	Cell"	"REF	20	23	Cell"	"T antigen	49	58	Gene_or_gene_product"	"p53	139	142	Gene_or_gene_product"	"MDM2	156	160	Gene_or_gene_product"	"p53	196	199	Gene_or_gene_product"	"p53	224	227	Gene_or_gene_product"	"T antigens	258	268	Gene_or_gene_product"	"5 - FU	287	293	Chemical"	"[{""token"": ""REF"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Cell""}, {""token"": ""REF"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Cell""}, {""token"": ""T antigen"", ""start_span"": 49, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}, {""token"": ""MDM2"", ""start_span"": 156, ""end_span"": 160, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 196, ""end_span"": 199, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 224, ""end_span"": 227, ""type"": ""Gene_or_gene_product""}, {""token"": ""T antigens"", ""start_span"": 258, ""end_span"": 268, ""type"": ""Gene_or_gene_product""}, {""token"": ""5 - FU"", ""start_span"": 287, ""end_span"": 293, ""type"": ""Chemical""}]"
Because there is little information on the expression of topo I in colorectal tumors, this study evaluated and characterized topo I protein expression in primary colorectal cancer and lymph node metastases and studied the association between topo I protein expression and clinicopathologic data, p53 status, and proliferating cell nuclear antigen ( PCNA) status.	"topo I	57	63	Gene_or_gene_product"	"colorectal tumors	67	84	Cancer"	"topo I	125	131	Gene_or_gene_product"	"colorectal cancer	162	179	Cancer"	"lymph node metastases	184	205	Cancer"	"topo I	242	248	Gene_or_gene_product"	"p53	296	299	Gene_or_gene_product"	"proliferating cell nuclear antigen	312	346	Gene_or_gene_product"	"PCNA	349	353	Gene_or_gene_product"	"[{""token"": ""topo I"", ""start_span"": 57, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""colorectal tumors"", ""start_span"": 67, ""end_span"": 84, ""type"": ""Cancer""}, {""token"": ""topo I"", ""start_span"": 125, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}, {""token"": ""colorectal cancer"", ""start_span"": 162, ""end_span"": 179, ""type"": ""Cancer""}, {""token"": ""lymph node metastases"", ""start_span"": 184, ""end_span"": 205, ""type"": ""Cancer""}, {""token"": ""topo I"", ""start_span"": 242, ""end_span"": 248, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 296, ""end_span"": 299, ""type"": ""Gene_or_gene_product""}, {""token"": ""proliferating cell nuclear antigen"", ""start_span"": 312, ""end_span"": 346, ""type"": ""Gene_or_gene_product""}, {""token"": ""PCNA"", ""start_span"": 349, ""end_span"": 353, ""type"": ""Gene_or_gene_product""}]"
METHODS: Expression of MMP - 9 was studied in human NPC cell lines cultured in vitro: CNE1 ( well differentiated cell line of NPC) and CNE1 - GL ( CNE1 cell line transfected with an eukaryotic LMP1 - expression plasmid) by SP immunohistochemistry and Western blot analysis.	"MMP - 9	23	30	Gene_or_gene_product"	"human	46	51	Organism"	"NPC cell lines	52	66	Cell"	"CNE1	86	90	Cell"	"cell line	113	122	Cell"	"NPC	126	129	Cell"	"CNE1 - GL	135	144	Cell"	"CNE1 cell line	147	161	Cell"	"LMP1	193	197	Gene_or_gene_product"	"[{""token"": ""MMP - 9"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Organism""}, {""token"": ""NPC cell lines"", ""start_span"": 52, ""end_span"": 66, ""type"": ""Cell""}, {""token"": ""CNE1"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Cell""}, {""token"": ""cell line"", ""start_span"": 113, ""end_span"": 122, ""type"": ""Cell""}, {""token"": ""NPC"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Cell""}, {""token"": ""CNE1 - GL"", ""start_span"": 135, ""end_span"": 144, ""type"": ""Cell""}, {""token"": ""CNE1 cell line"", ""start_span"": 147, ""end_span"": 161, ""type"": ""Cell""}, {""token"": ""LMP1"", ""start_span"": 193, ""end_span"": 197, ""type"": ""Gene_or_gene_product""}]"
Cell death induced by survivin targeting exhibited the hallmarks of mitochondrial - dependent apoptosis with release of cytochrome c and loss of mitochondrial transmembrane potential and was suppressed in Apaf - 1 or caspase - 9 knockout mouse embryonic fibroblasts.	"Cell	0	4	Cell"	"survivin	22	30	Gene_or_gene_product"	"mitochondrial	68	81	Cellular_component"	"cytochrome c	120	132	Gene_or_gene_product"	"mitochondrial	145	158	Cellular_component"	"Apaf - 1	205	213	Gene_or_gene_product"	"caspase - 9	217	228	Gene_or_gene_product"	"mouse	238	243	Organism"	"embryonic fibroblasts	244	265	Cell"	"[{""token"": ""Cell"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Cell""}, {""token"": ""survivin"", ""start_span"": 22, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitochondrial"", ""start_span"": 68, ""end_span"": 81, ""type"": ""Cellular_component""}, {""token"": ""cytochrome c"", ""start_span"": 120, ""end_span"": 132, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitochondrial"", ""start_span"": 145, ""end_span"": 158, ""type"": ""Cellular_component""}, {""token"": ""Apaf - 1"", ""start_span"": 205, ""end_span"": 213, ""type"": ""Gene_or_gene_product""}, {""token"": ""caspase - 9"", ""start_span"": 217, ""end_span"": 228, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 238, ""end_span"": 243, ""type"": ""Organism""}, {""token"": ""embryonic fibroblasts"", ""start_span"": 244, ""end_span"": 265, ""type"": ""Cell""}]"
In order to elucidate a mechanism for cancer - induced osteoclastogenesis, cells from a human breast cancer line, MDA - MB - 231, were directly co - cultured with ST2, MC3T3 - E1, or with primary mouse calvarial cells.	"cancer	38	44	Cancer"	"cells	75	80	Cell"	"human	88	93	Organism"	"breast cancer	94	107	Cancer"	"MDA - MB - 231	114	128	Cell"	"ST2	163	166	Cell"	"MC3T3 - E1	168	178	Cell"	"mouse	196	201	Organism"	"calvarial cells	202	217	Cell"	"[{""token"": ""cancer"", ""start_span"": 38, ""end_span"": 44, ""type"": ""Cancer""}, {""token"": ""cells"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Organism""}, {""token"": ""breast cancer"", ""start_span"": 94, ""end_span"": 107, ""type"": ""Cancer""}, {""token"": ""MDA - MB - 231"", ""start_span"": 114, ""end_span"": 128, ""type"": ""Cell""}, {""token"": ""ST2"", ""start_span"": 163, ""end_span"": 166, ""type"": ""Cell""}, {""token"": ""MC3T3 - E1"", ""start_span"": 168, ""end_span"": 178, ""type"": ""Cell""}, {""token"": ""mouse"", ""start_span"": 196, ""end_span"": 201, ""type"": ""Organism""}, {""token"": ""calvarial cells"", ""start_span"": 202, ""end_span"": 217, ""type"": ""Cell""}]"
After removal of fibroblasts by exposure to G - 418, the tumor cells exhibited increased metastatic ability and human K - ras oncogene mRNA, suggesting an intimate interaction between H - 3 cells and fibroblasts influencing the function of transfected human K - ras oncogene.	"fibroblasts	17	28	Cell"	"G - 418	44	51	Chemical"	"tumor cells	57	68	Cell"	"human	112	117	Organism"	"K - ras	118	125	Gene_or_gene_product"	"H - 3 cells	184	195	Cell"	"fibroblasts	200	211	Cell"	"human	252	257	Organism"	"K - ras	258	265	Gene_or_gene_product"	"[{""token"": ""fibroblasts"", ""start_span"": 17, ""end_span"": 28, ""type"": ""Cell""}, {""token"": ""G - 418"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Chemical""}, {""token"": ""tumor cells"", ""start_span"": 57, ""end_span"": 68, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Organism""}, {""token"": ""K - ras"", ""start_span"": 118, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""H - 3 cells"", ""start_span"": 184, ""end_span"": 195, ""type"": ""Cell""}, {""token"": ""fibroblasts"", ""start_span"": 200, ""end_span"": 211, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 252, ""end_span"": 257, ""type"": ""Organism""}, {""token"": ""K - ras"", ""start_span"": 258, ""end_span"": 265, ""type"": ""Gene_or_gene_product""}]"
One week later, IGF - 1 - transfected SMCs had increased myocardial IGF - 1 and VEGF levels, increased Bcl2 expression, limited cell apoptosis, and enhanced vessel formation in the myocardial scar compared with the two control groups ( P less than 0. 05 for all groups).	"IGF - 1	16	23	Gene_or_gene_product"	"SMCs	38	42	Cell"	"myocardial	57	67	Multi"	"IGF - 1	68	75	Gene_or_gene_product"	"VEGF	80	84	Gene_or_gene_product"	"Bcl2	103	107	Gene_or_gene_product"	"cell	128	132	Cell"	"vessel	157	163	Multi"	"myocardial scar	181	196	Pathological_formation"	"[{""token"": ""IGF - 1"", ""start_span"": 16, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""SMCs"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Cell""}, {""token"": ""myocardial"", ""start_span"": 57, ""end_span"": 67, ""type"": ""Multi""}, {""token"": ""IGF - 1"", ""start_span"": 68, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl2"", ""start_span"": 103, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Cell""}, {""token"": ""vessel"", ""start_span"": 157, ""end_span"": 163, ""type"": ""Multi""}, {""token"": ""myocardial scar"", ""start_span"": 181, ""end_span"": 196, ""type"": ""Pathological_formation""}]"
Hence, GM - CSF and IL - 3 enhance the intracellular metabolism of ara - C and its incorporation into the DNA of leukemic cells leading to a higher antileukemic activity of ara - C on clonogenic leukemic cells ( CFU - L).	"GM - CSF	7	15	Gene_or_gene_product"	"IL - 3	20	26	Gene_or_gene_product"	"intracellular	39	52	Immaterial_anatomical_entity"	"ara - C	67	74	Chemical"	"DNA	106	109	Cellular_component"	"leukemic cells	113	127	Cell"	"ara - C	173	180	Chemical"	"clonogenic leukemic cells	184	209	Cell"	"CFU - L	212	219	Cell"	"[{""token"": ""GM - CSF"", ""start_span"": 7, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 3"", ""start_span"": 20, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""intracellular"", ""start_span"": 39, ""end_span"": 52, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""ara - C"", ""start_span"": 67, ""end_span"": 74, ""type"": ""Chemical""}, {""token"": ""DNA"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Cellular_component""}, {""token"": ""leukemic cells"", ""start_span"": 113, ""end_span"": 127, ""type"": ""Cell""}, {""token"": ""ara - C"", ""start_span"": 173, ""end_span"": 180, ""type"": ""Chemical""}, {""token"": ""clonogenic leukemic cells"", ""start_span"": 184, ""end_span"": 209, ""type"": ""Cell""}, {""token"": ""CFU - L"", ""start_span"": 212, ""end_span"": 219, ""type"": ""Cell""}]"
In addition to p16 ( INK4A), the INK4A locus encodes a splice variant, termed p12 - - specifically expressed in human pancreas - - and ARF, a protein encoded by an alternative reading frame that acts as a tumor suppressor through the p53 pathway.	"p16	15	18	Gene_or_gene_product"	"INK4A	21	26	Gene_or_gene_product"	"INK4A	33	38	Gene_or_gene_product"	"p12	78	81	Gene_or_gene_product"	"human	112	117	Organism"	"pancreas	118	126	Organ"	"ARF	135	138	Gene_or_gene_product"	"tumor	205	210	Cancer"	"p53	234	237	Gene_or_gene_product"	"[{""token"": ""p16"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""INK4A"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""INK4A"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""p12"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Organism""}, {""token"": ""pancreas"", ""start_span"": 118, ""end_span"": 126, ""type"": ""Organ""}, {""token"": ""ARF"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 205, ""end_span"": 210, ""type"": ""Cancer""}, {""token"": ""p53"", ""start_span"": 234, ""end_span"": 237, ""type"": ""Gene_or_gene_product""}]"
To better understand the intracellular signaling pathways, we examined the effect of HKa on the phosphorylation of Akt and its downstream effector, GSK - 3alpha HKa and D5 inhibit phosphorylation of Akt and GSK - 3alpha after stimulation withVEGF and S1P.	"intracellular	25	38	Immaterial_anatomical_entity"	"HKa	85	88	Gene_or_gene_product"	"Akt	115	118	Gene_or_gene_product"	"GSK - 3alpha	148	160	Gene_or_gene_product"	"HKa	161	164	Gene_or_gene_product"	"Akt	199	202	Gene_or_gene_product"	"GSK - 3alpha	207	219	Gene_or_gene_product"	"withVEGF	238	246	Gene_or_gene_product"	"S1P	251	254	Gene_or_gene_product"	"[{""token"": ""intracellular"", ""start_span"": 25, ""end_span"": 38, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""HKa"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""GSK - 3alpha"", ""start_span"": 148, ""end_span"": 160, ""type"": ""Gene_or_gene_product""}, {""token"": ""HKa"", ""start_span"": 161, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 199, ""end_span"": 202, ""type"": ""Gene_or_gene_product""}, {""token"": ""GSK - 3alpha"", ""start_span"": 207, ""end_span"": 219, ""type"": ""Gene_or_gene_product""}, {""token"": ""withVEGF"", ""start_span"": 238, ""end_span"": 246, ""type"": ""Gene_or_gene_product""}, {""token"": ""S1P"", ""start_span"": 251, ""end_span"": 254, ""type"": ""Gene_or_gene_product""}]"
p63 also correlated with advanced pathological stage, tumor size, and the expression of human telomerase reverse transcriptase ( hTERT), tissue inhibitor of matrix metalloproteinase 1 ( TIMP1) and vascular endothelial growth factor ( VEGF).	"p63	0	3	Gene_or_gene_product"	"tumor	54	59	Cancer"	"human	88	93	Organism"	"telomerase reverse transcriptase	94	126	Gene_or_gene_product"	"hTERT	129	134	Gene_or_gene_product"	"tissue inhibitor of matrix metalloproteinase 1	137	183	Gene_or_gene_product"	"TIMP1	186	191	Gene_or_gene_product"	"vascular endothelial growth factor	197	231	Gene_or_gene_product"	"VEGF	234	238	Gene_or_gene_product"	"[{""token"": ""p63"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 54, ""end_span"": 59, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Organism""}, {""token"": ""telomerase reverse transcriptase"", ""start_span"": 94, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}, {""token"": ""hTERT"", ""start_span"": 129, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissue inhibitor of matrix metalloproteinase 1"", ""start_span"": 137, ""end_span"": 183, ""type"": ""Gene_or_gene_product""}, {""token"": ""TIMP1"", ""start_span"": 186, ""end_span"": 191, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 197, ""end_span"": 231, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 234, ""end_span"": 238, ""type"": ""Gene_or_gene_product""}]"
To elucidate the role of free radicals and leukocytes in MTX - induced oxidative organ damage and the putative protective effect of L - carnitine ( L - Car), Wistar albino rats were administered a single dose of MTX ( 20 mg / kg) followed by either saline or L - Car ( 500 mg / kg) for 5 days.	"leukocytes	43	53	Cell"	"MTX	57	60	Chemical"	"organ	81	86	Organ"	"L - carnitine	132	145	Chemical"	"L - Car	148	155	Chemical"	"Wistar albino rats	158	176	Organism"	"MTX	212	215	Chemical"	"saline	249	255	Chemical"	"L - Car	259	266	Chemical"	"[{""token"": ""leukocytes"", ""start_span"": 43, ""end_span"": 53, ""type"": ""Cell""}, {""token"": ""MTX"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Chemical""}, {""token"": ""organ"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Organ""}, {""token"": ""L - carnitine"", ""start_span"": 132, ""end_span"": 145, ""type"": ""Chemical""}, {""token"": ""L - Car"", ""start_span"": 148, ""end_span"": 155, ""type"": ""Chemical""}, {""token"": ""Wistar albino rats"", ""start_span"": 158, ""end_span"": 176, ""type"": ""Organism""}, {""token"": ""MTX"", ""start_span"": 212, ""end_span"": 215, ""type"": ""Chemical""}, {""token"": ""saline"", ""start_span"": 249, ""end_span"": 255, ""type"": ""Chemical""}, {""token"": ""L - Car"", ""start_span"": 259, ""end_span"": 266, ""type"": ""Chemical""}]"
To determine how p18 and p27 genetically interact with Men1, the tumor suppressor gene mutated in familial MEN1, we characterized p18 - Men1 and p27 - Men1 double mutant mice.	"p18	17	20	Gene_or_gene_product"	"p27	25	28	Gene_or_gene_product"	"Men1	55	59	Gene_or_gene_product"	"tumor	65	70	Cancer"	"MEN1	107	111	Cancer"	"p18	130	133	Gene_or_gene_product"	"Men1	136	140	Gene_or_gene_product"	"p27	145	148	Gene_or_gene_product"	"Men1	151	155	Gene_or_gene_product"	"[{""token"": ""p18"", ""start_span"": 17, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""p27"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""Men1"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Cancer""}, {""token"": ""MEN1"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Cancer""}, {""token"": ""p18"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""Men1"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}, {""token"": ""p27"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}, {""token"": ""Men1"", ""start_span"": 151, ""end_span"": 155, ""type"": ""Gene_or_gene_product""}]"
In the pituitary and pancreatic islets, phosphorylation of the retinoblastoma ( Rb) protein at both CDK2 and CDK4 / 6 sites was increased in p18 ( - / -) and Men1 ( + / -) cells and was further increased in p18 ( - / -); Men1 ( + / -) cells.	"pituitary	7	16	Multi"	"pancreatic islets	21	38	Multi"	"retinoblastoma	63	77	Gene_or_gene_product"	"Rb	80	82	Gene_or_gene_product"	"CDK2	100	104	Gene_or_gene_product"	"CDK4 / 6	109	117	Gene_or_gene_product"	"Men1	158	162	Gene_or_gene_product"	"p18	207	210	Gene_or_gene_product"	"Men1	221	225	Gene_or_gene_product"	"[{""token"": ""pituitary"", ""start_span"": 7, ""end_span"": 16, ""type"": ""Multi""}, {""token"": ""pancreatic islets"", ""start_span"": 21, ""end_span"": 38, ""type"": ""Multi""}, {""token"": ""retinoblastoma"", ""start_span"": 63, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rb"", ""start_span"": 80, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""CDK2"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""CDK4 / 6"", ""start_span"": 109, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""Men1"", ""start_span"": 158, ""end_span"": 162, ""type"": ""Gene_or_gene_product""}, {""token"": ""p18"", ""start_span"": 207, ""end_span"": 210, ""type"": ""Gene_or_gene_product""}, {""token"": ""Men1"", ""start_span"": 221, ""end_span"": 225, ""type"": ""Gene_or_gene_product""}]"
The results show that, without affecting in vitro human PMN viability and chemokine - receptor expression, Hyp ( as stable dicyclohexylammonium salt) was able to inhibit in a dose - dependent manner their chemotaxis and chemoinvasion ( IC50 = 1 microM for both); this effect was associated with a reduced expression of the adhesion molecule CD11b by formyl - Met - Leu - Phe - stimulated neutrophils and block of LE - triggered activation of the gelatinase matrix metalloproteinase - 9.	"human	50	55	Organism"	"PMN	56	59	Cell"	"Hyp	107	110	Chemical"	"dicyclohexylammonium salt	123	148	Chemical"	"CD11b	341	346	Gene_or_gene_product"	"formyl - Met - Leu - Phe	350	374	Chemical"	"neutrophils	388	399	Cell"	"LE	413	415	Gene_or_gene_product"	"gelatinase matrix metalloproteinase - 9	446	485	Gene_or_gene_product"	"[{""token"": ""human"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Organism""}, {""token"": ""PMN"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Cell""}, {""token"": ""Hyp"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Chemical""}, {""token"": ""dicyclohexylammonium salt"", ""start_span"": 123, ""end_span"": 148, ""type"": ""Chemical""}, {""token"": ""CD11b"", ""start_span"": 341, ""end_span"": 346, ""type"": ""Gene_or_gene_product""}, {""token"": ""formyl - Met - Leu - Phe"", ""start_span"": 350, ""end_span"": 374, ""type"": ""Chemical""}, {""token"": ""neutrophils"", ""start_span"": 388, ""end_span"": 399, ""type"": ""Cell""}, {""token"": ""LE"", ""start_span"": 413, ""end_span"": 415, ""type"": ""Gene_or_gene_product""}, {""token"": ""gelatinase matrix metalloproteinase - 9"", ""start_span"": 446, ""end_span"": 485, ""type"": ""Gene_or_gene_product""}]"
Statistically significant relationship between p53 expression in primary oral cancers and its expression in lymph node metastases ( P < 0. 02) as well as increased expression of Bcl - xL, Bax, and p53 in metastatic sites compared with primary tumors could indicate an association of these proteins with oral cancer progression and development of metastases.	"p53	47	50	Gene_or_gene_product"	"oral	73	77	Organism_subdivision"	"cancers	78	85	Cancer"	"lymph node	108	118	Multi"	"Bcl - xL	178	186	Gene_or_gene_product"	"Bax	188	191	Gene_or_gene_product"	"p53	197	200	Gene_or_gene_product"	"tumors	243	249	Cancer"	"oral cancer	303	314	Cancer"	"[{""token"": ""p53"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""oral"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Organism_subdivision""}, {""token"": ""cancers"", ""start_span"": 78, ""end_span"": 85, ""type"": ""Cancer""}, {""token"": ""lymph node"", ""start_span"": 108, ""end_span"": 118, ""type"": ""Multi""}, {""token"": ""Bcl - xL"", ""start_span"": 178, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bax"", ""start_span"": 188, ""end_span"": 191, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 197, ""end_span"": 200, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 243, ""end_span"": 249, ""type"": ""Cancer""}, {""token"": ""oral cancer"", ""start_span"": 303, ""end_span"": 314, ""type"": ""Cancer""}]"
Furthermore, there is strong evidence suggesting that aberrant activation of Wnt signaling induces mammary tumors from stem / progenitor cells, and that Wnt exerts its oncogenic effects through LRP5 / 6 - mediated activation of beta - catenin and mTOR pathways.	"Wnt	77	80	Gene_or_gene_product"	"mammary tumors	99	113	Cancer"	"stem	119	123	Cell"	"progenitor cells	126	142	Cell"	"Wnt	153	156	Gene_or_gene_product"	"LRP5	194	198	Gene_or_gene_product"	"6	201	202	Gene_or_gene_product"	"beta - catenin	228	242	Gene_or_gene_product"	"mTOR	247	251	Gene_or_gene_product"	"[{""token"": ""Wnt"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""mammary tumors"", ""start_span"": 99, ""end_span"": 113, ""type"": ""Cancer""}, {""token"": ""stem"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Cell""}, {""token"": ""progenitor cells"", ""start_span"": 126, ""end_span"": 142, ""type"": ""Cell""}, {""token"": ""Wnt"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}, {""token"": ""LRP5"", ""start_span"": 194, ""end_span"": 198, ""type"": ""Gene_or_gene_product""}, {""token"": ""6"", ""start_span"": 201, ""end_span"": 202, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta - catenin"", ""start_span"": 228, ""end_span"": 242, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 247, ""end_span"": 251, ""type"": ""Gene_or_gene_product""}]"
RUNX1 DNA - binding mutations and RUNX1 - PRDM16 cryptic fusions in BCR - ABL + leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance.	"RUNX1	0	5	Gene_or_gene_product"	"DNA	6	9	Cellular_component"	"RUNX1	34	39	Gene_or_gene_product"	"PRDM16	42	48	Gene_or_gene_product"	"BCR	68	71	Gene_or_gene_product"	"ABL	74	77	Gene_or_gene_product"	"21	139	141	Cellular_component"	"clonal	164	170	Cell"	"imatinib	185	193	Chemical"	"[{""token"": ""RUNX1"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Cellular_component""}, {""token"": ""RUNX1"", ""start_span"": 34, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""PRDM16"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""BCR"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""ABL"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""21"", ""start_span"": 139, ""end_span"": 141, ""type"": ""Cellular_component""}, {""token"": ""clonal"", ""start_span"": 164, ""end_span"": 170, ""type"": ""Cell""}, {""token"": ""imatinib"", ""start_span"": 185, ""end_span"": 193, ""type"": ""Chemical""}]"
To identify a suitable donor cell population for gene therapy applications to the central nervous system, primary fibroblasts isolated from skin biopsies and maintained in culture are employed as autologous cells for intracerebral grafting within the adult rat striatum.	"donor cell population	23	44	Cell"	"central nervous system	82	104	Anatomical_system"	"fibroblasts	114	125	Cell"	"skin biopsies	140	153	Multi"	"culture	172	179	Cell"	"cells	207	212	Cell"	"intracerebral	217	230	Immaterial_anatomical_entity"	"rat	257	260	Organism"	"striatum	261	269	Multi"	"[{""token"": ""donor cell population"", ""start_span"": 23, ""end_span"": 44, ""type"": ""Cell""}, {""token"": ""central nervous system"", ""start_span"": 82, ""end_span"": 104, ""type"": ""Anatomical_system""}, {""token"": ""fibroblasts"", ""start_span"": 114, ""end_span"": 125, ""type"": ""Cell""}, {""token"": ""skin biopsies"", ""start_span"": 140, ""end_span"": 153, ""type"": ""Multi""}, {""token"": ""culture"", ""start_span"": 172, ""end_span"": 179, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 207, ""end_span"": 212, ""type"": ""Cell""}, {""token"": ""intracerebral"", ""start_span"": 217, ""end_span"": 230, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""rat"", ""start_span"": 257, ""end_span"": 260, ""type"": ""Organism""}, {""token"": ""striatum"", ""start_span"": 261, ""end_span"": 269, ""type"": ""Multi""}]"
Inhibition of p38 SAPK reduced CBP HAT activity and its recruitment to the SRF. MRTF - A complex, whereas enforced induction of p38 by upstream activators ( e. g. MKK3 and MKK6) enhanced both CBP HAT and CCN1 promoter activities.	"p38 SAPK	14	22	Gene_or_gene_product"	"CBP HAT	31	38	Gene_or_gene_product"	"SRF	75	78	Gene_or_gene_product"	"MRTF - A	80	88	Gene_or_gene_product"	"p38	128	131	Gene_or_gene_product"	"MKK3	163	167	Gene_or_gene_product"	"MKK6	172	176	Gene_or_gene_product"	"CBP HAT	192	199	Gene_or_gene_product"	"CCN1	204	208	Gene_or_gene_product"	"[{""token"": ""p38 SAPK"", ""start_span"": 14, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""CBP HAT"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""SRF"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""MRTF - A"", ""start_span"": 80, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""p38"", ""start_span"": 128, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}, {""token"": ""MKK3"", ""start_span"": 163, ""end_span"": 167, ""type"": ""Gene_or_gene_product""}, {""token"": ""MKK6"", ""start_span"": 172, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}, {""token"": ""CBP HAT"", ""start_span"": 192, ""end_span"": 199, ""type"": ""Gene_or_gene_product""}, {""token"": ""CCN1"", ""start_span"": 204, ""end_span"": 208, ""type"": ""Gene_or_gene_product""}]"
Nontumorigenic, immortalized keratinocytes cell line ( 3PC), papilloma ( MT1 / 2), and squamous cell carcinoma ( Ca3 / 7) cell lines were initially used to study the cell growth inhibition by DMI.	"keratinocytes cell line	29	52	Cell"	"3PC	55	58	Cell"	"papilloma	61	70	Cell"	"MT1 / 2	73	80	Cell"	"squamous cell carcinoma	87	110	Cell"	"Ca3 / 7	113	120	Cell"	"cell lines	122	132	Cell"	"cell	166	170	Cell"	"DMI	192	195	Chemical"	"[{""token"": ""keratinocytes cell line"", ""start_span"": 29, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""3PC"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Cell""}, {""token"": ""papilloma"", ""start_span"": 61, ""end_span"": 70, ""type"": ""Cell""}, {""token"": ""MT1 / 2"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Cell""}, {""token"": ""squamous cell carcinoma"", ""start_span"": 87, ""end_span"": 110, ""type"": ""Cell""}, {""token"": ""Ca3 / 7"", ""start_span"": 113, ""end_span"": 120, ""type"": ""Cell""}, {""token"": ""cell lines"", ""start_span"": 122, ""end_span"": 132, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 166, ""end_span"": 170, ""type"": ""Cell""}, {""token"": ""DMI"", ""start_span"": 192, ""end_span"": 195, ""type"": ""Chemical""}]"
Measurements of respiration, CO2 and lactate production, and changes in the levels of various key metabolites of the glycolytic sequence and tricarboxylic acid cycle were made on five lines of rodent ascites tumor cells ( two strains of Ehrlich ascites tumor cells, Krebs II carcinoma, AS - 30D carcinoma, and L1210 cells) incubated aerobically in the presence of uniformly labeled D - [ 14C] glucose.	"CO2	29	32	Chemical"	"lactate	37	44	Chemical"	"tricarboxylic acid	141	159	Chemical"	"rodent	193	199	Organism"	"ascites tumor cells	200	219	Cell"	"Ehrlich ascites tumor cells	237	264	Cell"	"Krebs II carcinoma	266	284	Cell"	"AS - 30D carcinoma	286	304	Cell"	"L1210 cells	310	321	Cell"	"[{""token"": ""CO2"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Chemical""}, {""token"": ""lactate"", ""start_span"": 37, ""end_span"": 44, ""type"": ""Chemical""}, {""token"": ""tricarboxylic acid"", ""start_span"": 141, ""end_span"": 159, ""type"": ""Chemical""}, {""token"": ""rodent"", ""start_span"": 193, ""end_span"": 199, ""type"": ""Organism""}, {""token"": ""ascites tumor cells"", ""start_span"": 200, ""end_span"": 219, ""type"": ""Cell""}, {""token"": ""Ehrlich ascites tumor cells"", ""start_span"": 237, ""end_span"": 264, ""type"": ""Cell""}, {""token"": ""Krebs II carcinoma"", ""start_span"": 266, ""end_span"": 284, ""type"": ""Cell""}, {""token"": ""AS - 30D carcinoma"", ""start_span"": 286, ""end_span"": 304, ""type"": ""Cell""}, {""token"": ""L1210 cells"", ""start_span"": 310, ""end_span"": 321, ""type"": ""Cell""}]"
Class - 3 semaphorins, semaphorin - 3B ( SEMA3B) and semaphorin - 3F ( SEMA3F), illustrate their effects by forming a complex with neuropilins ( NP - 1 or NP - 2) and plexins.	"Class - 3 semaphorins	0	21	Gene_or_gene_product"	"semaphorin - 3B	23	38	Gene_or_gene_product"	"SEMA3B	41	47	Gene_or_gene_product"	"semaphorin - 3F	53	68	Gene_or_gene_product"	"SEMA3F	71	77	Gene_or_gene_product"	"neuropilins	131	142	Gene_or_gene_product"	"NP - 1	145	151	Gene_or_gene_product"	"NP - 2	155	161	Gene_or_gene_product"	"plexins	167	174	Gene_or_gene_product"	"[{""token"": ""Class - 3 semaphorins"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""semaphorin - 3B"", ""start_span"": 23, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""SEMA3B"", ""start_span"": 41, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""semaphorin - 3F"", ""start_span"": 53, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""SEMA3F"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuropilins"", ""start_span"": 131, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}, {""token"": ""NP - 1"", ""start_span"": 145, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""NP - 2"", ""start_span"": 155, ""end_span"": 161, ""type"": ""Gene_or_gene_product""}, {""token"": ""plexins"", ""start_span"": 167, ""end_span"": 174, ""type"": ""Gene_or_gene_product""}]"
Available data indicate that the timing of telomerase activation may allow the distinction of two different lymphomagenetic models: ( i) an early activation of telomerase via exogenous regulators of hTERT, along with an increased lymphocyte growth and a subsequent selection of cells with increased transforming potential may characterize several virus - related lymphoid malignancies; ( ii) a progressive shortening of telomeres, leading to genetic instability which favors a subsequent activation of telomerase via endogenous regulators may occur in most virus - unrelated lymphoid tumors.	"telomerase	43	53	Gene_or_gene_product"	"telomerase	160	170	Gene_or_gene_product"	"hTERT	199	204	Gene_or_gene_product"	"lymphocyte	230	240	Cell"	"cells	278	283	Cell"	"lymphoid malignancies	363	384	Pathological_formation"	"telomeres	420	429	Cellular_component"	"telomerase	502	512	Gene_or_gene_product"	"lymphoid tumors	575	590	Cancer"	"[{""token"": ""telomerase"", ""start_span"": 43, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""telomerase"", ""start_span"": 160, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""hTERT"", ""start_span"": 199, ""end_span"": 204, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymphocyte"", ""start_span"": 230, ""end_span"": 240, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 278, ""end_span"": 283, ""type"": ""Cell""}, {""token"": ""lymphoid malignancies"", ""start_span"": 363, ""end_span"": 384, ""type"": ""Pathological_formation""}, {""token"": ""telomeres"", ""start_span"": 420, ""end_span"": 429, ""type"": ""Cellular_component""}, {""token"": ""telomerase"", ""start_span"": 502, ""end_span"": 512, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymphoid tumors"", ""start_span"": 575, ""end_span"": 590, ""type"": ""Cancer""}]"
While betulin exhibited only moderate anticancer activity in other human cancer cells such as hepatoma SK - HEP - 1 cells, prostate carcinoma PC - 3, and lung carcinoma NCI - H460, with IC ( 50) values ranging from 20 to 60 microg / mL, it showed minor growth inhibition in human erythroleukemia K562 cells ( IC ( 50) > 100 microg / mL).	"betulin	6	13	Chemical"	"anticancer	38	48	Cancer"	"human	67	72	Organism"	"cancer cells	73	85	Cell"	"hepatoma SK - HEP - 1 cells	94	121	Cell"	"prostate carcinoma PC - 3	123	148	Cell"	"lung carcinoma NCI - H460	154	179	Cell"	"human	274	279	Organism"	"erythroleukemia K562 cells	280	306	Cell"	"[{""token"": ""betulin"", ""start_span"": 6, ""end_span"": 13, ""type"": ""Chemical""}, {""token"": ""anticancer"", ""start_span"": 38, ""end_span"": 48, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Organism""}, {""token"": ""cancer cells"", ""start_span"": 73, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""hepatoma SK - HEP - 1 cells"", ""start_span"": 94, ""end_span"": 121, ""type"": ""Cell""}, {""token"": ""prostate carcinoma PC - 3"", ""start_span"": 123, ""end_span"": 148, ""type"": ""Cell""}, {""token"": ""lung carcinoma NCI - H460"", ""start_span"": 154, ""end_span"": 179, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 274, ""end_span"": 279, ""type"": ""Organism""}, {""token"": ""erythroleukemia K562 cells"", ""start_span"": 280, ""end_span"": 306, ""type"": ""Cell""}]"
METHODOLOGY / PRINCIPAL FINDINGS: Examination of FOXO3a and phosphorylated - Akt ( P - Akt) expression in breast cancer tissue microarrays showed nuclear FOXO3a was associated with lymph node positivity ( p = 0. 052), poor prognosis ( p = 0. 014), and P - Akt expression in invasive ductal carcinoma.	"FOXO3a	49	55	Gene_or_gene_product"	"Akt	77	80	Gene_or_gene_product"	"Akt	87	90	Gene_or_gene_product"	"breast cancer tissue	106	126	Cancer"	"nuclear	146	153	Cellular_component"	"FOXO3a	154	160	Gene_or_gene_product"	"lymph node	181	191	Multi"	"Akt	256	259	Gene_or_gene_product"	"invasive ductal carcinoma	274	299	Cancer"	"[{""token"": ""FOXO3a"", ""start_span"": 49, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer tissue"", ""start_span"": 106, ""end_span"": 126, ""type"": ""Cancer""}, {""token"": ""nuclear"", ""start_span"": 146, ""end_span"": 153, ""type"": ""Cellular_component""}, {""token"": ""FOXO3a"", ""start_span"": 154, ""end_span"": 160, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 181, ""end_span"": 191, ""type"": ""Multi""}, {""token"": ""Akt"", ""start_span"": 256, ""end_span"": 259, ""type"": ""Gene_or_gene_product""}, {""token"": ""invasive ductal carcinoma"", ""start_span"": 274, ""end_span"": 299, ""type"": ""Cancer""}]"
Using tamoxifen and doxorubicin - sensitive and - resistant breast cancer cell lines as models, we found that doxorubicin - but not tamoxifen - resistance is associated with nuclear accumulation of FOXO3a, consistent with the finding that sustained nuclear FOXO3a is associated with poor prognosis.	"tamoxifen	6	15	Chemical"	"doxorubicin	20	31	Chemical"	"breast cancer cell lines	60	84	Cell"	"doxorubicin	110	121	Chemical"	"tamoxifen	132	141	Chemical"	"nuclear	174	181	Cellular_component"	"FOXO3a	198	204	Gene_or_gene_product"	"nuclear	249	256	Cellular_component"	"FOXO3a	257	263	Gene_or_gene_product"	"[{""token"": ""tamoxifen"", ""start_span"": 6, ""end_span"": 15, ""type"": ""Chemical""}, {""token"": ""doxorubicin"", ""start_span"": 20, ""end_span"": 31, ""type"": ""Chemical""}, {""token"": ""breast cancer cell lines"", ""start_span"": 60, ""end_span"": 84, ""type"": ""Cell""}, {""token"": ""doxorubicin"", ""start_span"": 110, ""end_span"": 121, ""type"": ""Chemical""}, {""token"": ""tamoxifen"", ""start_span"": 132, ""end_span"": 141, ""type"": ""Chemical""}, {""token"": ""nuclear"", ""start_span"": 174, ""end_span"": 181, ""type"": ""Cellular_component""}, {""token"": ""FOXO3a"", ""start_span"": 198, ""end_span"": 204, ""type"": ""Gene_or_gene_product""}, {""token"": ""nuclear"", ""start_span"": 249, ""end_span"": 256, ""type"": ""Cellular_component""}, {""token"": ""FOXO3a"", ""start_span"": 257, ""end_span"": 263, ""type"": ""Gene_or_gene_product""}]"
Furthermore, the expression levels of NF - kappaB - regulated metastasis - related molecules, such as fibronectin, beta1 integrin, MMP - 1, - 2, - 9, and - 14, and VEGF - C, were upregulated in the highly metastatic cells.	"NF - kappaB	38	49	Gene_or_gene_product"	"fibronectin	102	113	Gene_or_gene_product"	"beta1 integrin	115	129	Gene_or_gene_product"	"MMP - 1	131	138	Gene_or_gene_product"	"- 2	140	143	Gene_or_gene_product"	"- 9	145	148	Gene_or_gene_product"	"- 14	154	158	Gene_or_gene_product"	"VEGF - C	164	172	Gene_or_gene_product"	"cells	216	221	Cell"	"[{""token"": ""NF - kappaB"", ""start_span"": 38, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibronectin"", ""start_span"": 102, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta1 integrin"", ""start_span"": 115, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 1"", ""start_span"": 131, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 2"", ""start_span"": 140, ""end_span"": 143, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 9"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 14"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C"", ""start_span"": 164, ""end_span"": 172, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 216, ""end_span"": 221, ""type"": ""Cell""}]"
Two approaches were used to measure protein kinase C: assay of intact cells for inhibition of epidermal growth factor ( EGF) binding in response to phorbol dibutyrate ( PDBu); and assay of detergent extracts for total calcium, phospholipid - dependent kinase activity.	"protein kinase C	36	52	Gene_or_gene_product"	"cells	70	75	Cell"	"epidermal growth factor	94	117	Gene_or_gene_product"	"EGF	120	123	Gene_or_gene_product"	"phorbol dibutyrate	148	166	Chemical"	"PDBu	169	173	Chemical"	"extracts	199	207	Organism_substance"	"calcium	218	225	Chemical"	"phospholipid	227	239	Chemical"	"[{""token"": ""protein kinase C"", ""start_span"": 36, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 70, ""end_span"": 75, ""type"": ""Cell""}, {""token"": ""epidermal growth factor"", ""start_span"": 94, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGF"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}, {""token"": ""phorbol dibutyrate"", ""start_span"": 148, ""end_span"": 166, ""type"": ""Chemical""}, {""token"": ""PDBu"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Chemical""}, {""token"": ""extracts"", ""start_span"": 199, ""end_span"": 207, ""type"": ""Organism_substance""}, {""token"": ""calcium"", ""start_span"": 218, ""end_span"": 225, ""type"": ""Chemical""}, {""token"": ""phospholipid"", ""start_span"": 227, ""end_span"": 239, ""type"": ""Chemical""}]"
The human T - cell leukemia viruses HTLV - I and HTLV - II are unique among the transforming retroviruses of vertebrates in their ability to transform human T cells in vitro and in their close association with human malignancies ( T - cell lymphomas and leukemia).	"human T - cell leukemia viruses HTLV - I	4	44	Organism"	"HTLV - II	49	58	Organism"	"retroviruses	93	105	Organism"	"human	151	156	Organism"	"T cells	157	164	Cell"	"human	210	215	Organism"	"malignancies	216	228	Cancer"	"T - cell lymphomas	231	249	Cancer"	"leukemia	254	262	Cancer"	"[{""token"": ""human T - cell leukemia viruses HTLV - I"", ""start_span"": 4, ""end_span"": 44, ""type"": ""Organism""}, {""token"": ""HTLV - II"", ""start_span"": 49, ""end_span"": 58, ""type"": ""Organism""}, {""token"": ""retroviruses"", ""start_span"": 93, ""end_span"": 105, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 151, ""end_span"": 156, ""type"": ""Organism""}, {""token"": ""T cells"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 210, ""end_span"": 215, ""type"": ""Organism""}, {""token"": ""malignancies"", ""start_span"": 216, ""end_span"": 228, ""type"": ""Cancer""}, {""token"": ""T - cell lymphomas"", ""start_span"": 231, ""end_span"": 249, ""type"": ""Cancer""}, {""token"": ""leukemia"", ""start_span"": 254, ""end_span"": 262, ""type"": ""Cancer""}]"
Although insulin sensitivity of skeletal muscle was also reduced in patients with lymphoma, the net insulin effect may counteract imbalance between glucose uptake of tumor and muscle, offering a potential means to circumvent at least some metabolic abnormalities found in cancer.	"insulin	9	16	Gene_or_gene_product"	"skeletal muscle	32	47	Organ"	"patients	68	76	Organism"	"lymphoma	82	90	Cancer"	"insulin	100	107	Gene_or_gene_product"	"glucose	148	155	Chemical"	"tumor	166	171	Cancer"	"muscle	176	182	Organ"	"cancer	272	278	Cancer"	"[{""token"": ""insulin"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""skeletal muscle"", ""start_span"": 32, ""end_span"": 47, ""type"": ""Organ""}, {""token"": ""patients"", ""start_span"": 68, ""end_span"": 76, ""type"": ""Organism""}, {""token"": ""lymphoma"", ""start_span"": 82, ""end_span"": 90, ""type"": ""Cancer""}, {""token"": ""insulin"", ""start_span"": 100, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""glucose"", ""start_span"": 148, ""end_span"": 155, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 166, ""end_span"": 171, ""type"": ""Cancer""}, {""token"": ""muscle"", ""start_span"": 176, ""end_span"": 182, ""type"": ""Organ""}, {""token"": ""cancer"", ""start_span"": 272, ""end_span"": 278, ""type"": ""Cancer""}]"
Plasmid DNA encoding each of the three principal human VEGF isoforms ( phVEGF121, phVEGF165, or phVEGF189) was applied to the hydrogel polymer coating of an angioplasty balloon and delivered percutaneously to one iliac artery of rabbits with operatively induced hindlimb ischemia.	"Plasmid DNA	0	11	Cellular_component"	"human	49	54	Organism"	"VEGF	55	59	Gene_or_gene_product"	"phVEGF121	71	80	Gene_or_gene_product"	"phVEGF165	82	91	Gene_or_gene_product"	"phVEGF189	96	105	Gene_or_gene_product"	"iliac artery	213	225	Multi"	"rabbits	229	236	Organism"	"hindlimb	262	270	Organism_subdivision"	"[{""token"": ""Plasmid DNA"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Cellular_component""}, {""token"": ""human"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Organism""}, {""token"": ""VEGF"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""phVEGF121"", ""start_span"": 71, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""phVEGF165"", ""start_span"": 82, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""phVEGF189"", ""start_span"": 96, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""iliac artery"", ""start_span"": 213, ""end_span"": 225, ""type"": ""Multi""}, {""token"": ""rabbits"", ""start_span"": 229, ""end_span"": 236, ""type"": ""Organism""}, {""token"": ""hindlimb"", ""start_span"": 262, ""end_span"": 270, ""type"": ""Organism_subdivision""}]"
Although extracellular signal - regulated protein kinase 1 / 2 ( ERK1 / 2), c - Jun N - terminal kinase 1 ( JNK1), and p38 were activated after denudation, the activation of ERK1 and p38 was more rapid and prominent.	"extracellular signal - regulated protein kinase 1	9	58	Gene_or_gene_product"	"2	61	62	Gene_or_gene_product"	"ERK1	65	69	Gene_or_gene_product"	"2	72	73	Gene_or_gene_product"	"c - Jun N - terminal kinase 1	76	105	Gene_or_gene_product"	"JNK1	108	112	Gene_or_gene_product"	"p38	119	122	Gene_or_gene_product"	"ERK1	174	178	Gene_or_gene_product"	"p38	183	186	Gene_or_gene_product"	"[{""token"": ""extracellular signal - regulated protein kinase 1"", ""start_span"": 9, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""2"", ""start_span"": 61, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK1"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""2"", ""start_span"": 72, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - Jun N - terminal kinase 1"", ""start_span"": 76, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""JNK1"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""p38"", ""start_span"": 119, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK1"", ""start_span"": 174, ""end_span"": 178, ""type"": ""Gene_or_gene_product""}, {""token"": ""p38"", ""start_span"": 183, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}]"
